Synteract is a full-service, international CRO

Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I - IV clinical studies with support services that address their specific needs.

Synteract is a full-service, international CRO

We are dedicated to bringing new treatments to market, working closely with our clients in a spirit of “Shared Work – Shared Vision.” Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the continuum of Phase I - IV clinical studies with support services that address their specific needs. Together, we can bring tomorrow’s treatments to patients who need them, today.

Special Announcements!

Welcome to our redesigned website.
At Synteract, our CRO services are grounded in shared values, real people and deep expertise in clinical development to provide timely results. We invite you to meet the people who make up our CRO company and learn how we are different, through case studies, articles, blog posts and other clear examples of our “Shared Work – Shared Vision” philosophy.

Latest News & Events

1/22/2018 - 1/25/2018 : Cell & Gene Therapy World More...

1/17/2018: Synteract, a full-service, international contract research organization (CRO), announced today that Karl Deonanan has joined as chief financial officer (CFO). More ...

11/20/2017: Thought leaders from Synteract, a full-service, international contract research organization (CRO), will exhibit and present at Partnerships in Clinical Trials Europe (PCT), November 28-29, Amsterdam, Netherlands. More ...

Get in Touch

Global Headquarters:
5909 Sea Otter Place
Suite 100
Carlsbad, CA 92010

Phone: +1 760 268 8200
Fax: +1 760 929 1419

11/28/2017: Join Us at Partnerships in Clinical Trials Europe - Join us for coffee and conversation at booth #17 at Partnerships in Clinical Trials Europe (PCT), November 28-29 in Amsterdam, Netherlands.
Synteract Blog

Connect With Us

1/18/2018: We'll be attending the Cell & Gene Therapy World conference January 22-25 in Miami. Contact Erin Tabet or Alexandre WALLARD MSc Ing to set up a time to meet with our team.  Along with Erin and Alexandre, our Executive Director of Strategic Development, Linda Rawlings will be in attendance and available for meetings. See you in Miami! https://lnkd.in/ghytPnh
Synteract on LinkedIn

Follow Us

1/18/2018: We'll be attending the Cell & Gene Therapy World Conference January 22-25 in Miami. Let us know if you will be atte… https://t.co/G3b8H7E0FB
Synteract Twitter Feed

x

Contact Synteract

Tell us how to stay in touch with you:

*Required